Quarterly report pursuant to sections 13 or 15(d)

Stock Based Compensation

v2.3.0.15
Stock Based Compensation
9 Months Ended
Jul. 31, 2011
Stock Based Compensation  
Stock Based Compensation
2.

STOCK BASED COMPENSATION

We maintain stock equity incentive plans under which we may grant non-qualified stock options, stock appreciation rights, stock awards, performance awards, or stock units to employees, directors and consultants.

Stock Option Compensation Expense

We account for stock options granted to employees and directors using the accounting guidance in ASC 718 "Stock Compensation" ("ASC 718"). In accordance with ASC 718, we estimate the fair value of stock options granted on the date of grant using the Black-Scholes pricing model. We recognize compensation expense for stock option awards on a straight-line basis over the requisite service period of the grant. We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $643,000 and $535,000, during the nine-month periods ended July 31, 2011 and 2010, respectively, and of approximately $334,000 and $96,000, during the three-month periods ended July 31, 2011 and 2010, respectively. Such compensation expense is included in the accompanying condensed consolidated statements of operations in either research and development expenses or selling, general and administrative expenses, as applicable based on the functions performed by such employees and directors.

The stock-based compensation cost for stock options granted in prior periods but not yet vested, included in compensation expense related to stock options granted to employees and directors, recorded during the nine-month periods ended July 31, 2011 and 2010 was approximately $8,000 and $18,000, respectively, and during the three-month periods ended July 31, 2011 and 2010 was approximately $4,000 and $6,000, respectively. As of July 31, 2011, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements for stock options granted to employees and directors.

We account for stock options granted to consultants using the accounting guidance under ASC 505-50 "Equity-Based Payments to Non-Employees" ("ASC 505-50"). In accordance with ASC 505-50, we estimate the fair value of stock options granted on the date of grant using the Black-Scholes pricing model. We recognized consulting expense for options granted to non-employee consultants, during the nine-month periods ended July 31, 2011 and 2010, of approximately $44,000 and $6,000, respectively and during the three-month periods ended July 31, 2011 and July 31, 2010, of $-0- and $-0-, respectively. Such consulting expense is included in the accompanying condensed consolidated statements of operations in either research and development expenses or selling, general and administrative expenses, as applicable based on the functions performed by such consultants. As of July 31, 2011, there was no unrecognized consulting expense related to non-vested share-based compensation arrangements for stock options granted to consultants.

Fair Value Determination

We separate the employees and directors we grant stock options to into three relatively homogenous groups, based on exercise and post-vesting employment termination behaviors. To determine the weighted average fair value of stock options on the date of grant for options granted to employees and directors, we take a weighted average of the assumptions used for each of these groups. The fair value of stock options granted to consultants is determined on an individual basis. Stock options we granted during the nine months ended July 31, 2011 and 2010 consisted of awards of options with 10-year terms which vested immediately.

The following weighted average assumptions were used in estimating the fair value of stock options granted during the nine and three months ended July 31, 2011 and 2010.

 

     For the Nine Months
Ended  July 31,
  For the Three Months
Ended  July 31,
         2011           2010           2011           2010    

Weighted average fair value at grant date

   $0.16   $0.21   $0.25   $0.11

Valuation assumptions:

        

Expected life ( years)

   3.64   1.9   4.92   1.8

Expected volatility

   102%   106%   105%   96%

Risk-free interest rate

   1.05%   .70%   1.48%   .58%

Expected dividend yield

   0   0   0   0

The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. Actual historical performance is used for awards exercised or cancelled. For awards that remain unexercised and outstanding, even exercise over the remaining contractual term is assumed. Each category is weighted for its relative size in the population and is then multiplied by the indicated expected term for each category to arrive at the expected term for the population. We estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options. We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants. We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future. Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest. Accordingly, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options. We estimated expected forfeitures based on our historical experience.

 

We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate, or if grants issued in future periods have characteristics that cannot be reasonably estimated using this model. If factors change and we employ different assumptions in the application of ASC 718 and ASC 505-50 in future periods, the compensation expense that we record may differ significantly from what we have recorded in the current period.

Stock Option Activity

During the nine-month periods ended July 31, 2011 and 2010, we granted options to purchase 4,125,000 shares and 2,460,000 shares, respectively, to employees, directors and consultants of common stock at weighted average exercise prices of $.26 and $0.41 per share, respectively, pursuant to the CopyTele, Inc. 2003 Share Incentive Plan (the "2003 Share Plan") and the CopyTele, Inc. 2010 Share Incentive Plan (the "2010 Share Plan). During the nine-month periods ended July 31, 2011 and 2010, stock options to purchase 4,670,000 shares and 2,515,000 shares, respectively, of common stock were exercised with aggregate proceeds of approximately $1,099,000 and $1,050,000, respectively.

Stock Option Plans

As of July 31, 2011, we have three stock option plans: the CopyTele, Inc. 2000 Share Incentive Plan ("2000 Share Plan"), the 2003 Share Plan, and the 2010 Share Plan, which were adopted by our Board of Directors on May 8, 2000, April 21, 2003 and July 14, 2010, respectively.

In accordance with the provisions thereof, the 2000 Share Plan terminated with respect to the grant of future options on May 8, 2010. The exercise price with respect to all of the stock options granted under the 2000 Share Plan, since its inception, was equal to the fair market value of the underlying common stock at the grant date. Information regarding the 2000 Share Plan for the nine months ended July 31, 2011 is as follows:

 

     Shares     Weighted
Average Exercise
Price Per Share
   Aggregate
Intrinsic
Value

Options Outstanding and Exercisable at October 31, 2010

     870,466      $0.66   

Expired

     (655,466   $0.75   
  

 

 

      

Options Outstanding and Exercisable at July 31, 2011

     215,000      $0.40    $ -0-
  

 

 

      

The following table summarizes information about stock options outstanding under the 2000 Share Plan as of July 31, 2011:

 

     Options Outstanding and Exercisable  

Range of
Exercise

Prices

   Number
Outstanding
     Weighted
Average
Remaining
Contractual
Life (in years)
     Weighted
Average
Exercise
Price
 

$0.40

     215,000         0.14       $ 0.40   

The 2003 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards, and stock units to key employees and consultants. The maximum number of shares of common stock available for issuance under the 2003 Share Plan is 70,000,000 shares. The 2003 Share Plan is administered by the Board of Directors, which determines the option price, term, and provisions of each option. The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. As of July 31, 2011, the 2003 Share Plan had 118,650 shares available for future grants. Information regarding the 2003 Share Plan for the nine months ended July 31, 2011 is as follows:

 

     Shares     Weighted
Average Exercise
Price Per Share
   Aggregate
Intrinsic
Value

Options Outstanding and Exercisable at October 31, 2010

     18,112,045      $0.80   

Exercised

     (500,000   $0.25   
  

 

 

      

Options Outstanding and Exercisable at July 31, 2011

     17,612,045      $0.81    $ -0-
  

 

 

      

The following table summarizes information about stock options outstanding under the 2003 Share Plan as of July 31, 2011:

 

     Options Outstanding & Exercisable

Range of
Exercise

Prices

   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life (in years)
   Weighted
Average
Exercise
Price

$0.25 - $0.65

   4,660,970    3.79    $0.57

$0.68 - $0.84

   5,156,075    5.07    $0.79

$0.86 - $0.92

   4,665,000    6.10    $0.84

$1.04 - $1.46

   3,130,000    4.41    $1.10

The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards, and stock units to key employees and consultants. The maximum number of shares of common stock available for issuance under the 2010 Share Plan was initially 15,000,000 shares. On July 6, 2011 the 2010 Share Plan was amended by our Board of Directors to increase the maximum number of shares of common stock that may be granted to 27,000,000 shares. Current and future non-employee directors are automatically granted nonqualified stock options to purchase up to 60,000 shares of common stock upon their initial election to the Board of Directors and 60,000 shares of common stock at the time of each subsequent annual meeting of our shareholders at which they are elected to the Board of Directors. The 2010 Share Plan is administered by the Board of Directors, which determines the option price, term, and provisions of each option. The exercise price with respect to the options granted under the 2010 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. As of July 31, 2011, the 2010 Share Plan had 11,450,645 shares available for future grants. Information regarding the 2010 Share Plan for the nine months ended July 31, 2011 is as follows:

 

     Shares     Weighted
Average Exercise
Price Per Share
   Aggregate
Intrinsic
Value

Options Outstanding at October 31, 2010

     1,035,000      $0.21   

Granted

     4,125,000      $0.26   

Exercised

     (4,170,000   $0.23   
  

 

 

      

Options Outstanding and Exercisable at July 31, 2011

     990,000      $0.32    $10,050
  

 

 

      

The following table summarizes information about stock options outstanding under the 2010 Share Plan as of July 31, 2011:

 

     Options Outstanding & Exercisable  

Range of
Exercise

Prices

   Number
Outstanding
     Weighted
Average
Remaining
Contractual
Life (in years)
     Weighted
Average
Exercise
Price
 

$0.18 - $0.37

     990,000         9.76       $ 0.32   

Stock Awards

We account for stock awards granted to employees and consultants based on their grant date fair value, in accordance with ASC 718 and ASC 505-50, respectively. During the nine-month periods ended July 31, 2011 and 2010, we issued 6,396,075 shares and 3,467,425 shares, respectively, of common stock to certain employees for services rendered, principally in lieu of cash compensation, pursuant to the 2010 Share Plan and the 2003 Share Plan. We recorded compensation expense for the nine-month periods ended July 31, 2011 and 2010, of approximately $1,313,000 and $1,392,000, respectively, and for the three-month periods ended July 31, 2011 and 2010, of approximately $353,000 and $398,000, respectively, for the shares of common stock issued to employees. Such compensation expense is included in the accompanying condensed consolidated statements of operations in either research and development expenses or selling, general and administrative expenses, as applicable based on the functions performed by such employees and directors. In addition, during the nine-month periods ended July 31, 2011 and 2010, we issued 345,794 shares and 117,285 shares, respectively, of common stock to consultants for services rendered pursuant to the 2010 Share Plan and the 2003 Share Plan. We recorded consulting expense for the nine-month periods ended July 31, 2011 and 2010 of approximately $84,000 and $53,000, respectively, and for the three-month periods ended July 31, 2011 and 2010 of approximately $48,000 and $11,000, respectively for the shares of common stock issued to consultants. Such consulting expense is included in the accompanying condensed consolidated statements of operations in either research and development expenses or selling, general and administrative expenses, as applicable based on the functions performed by such consultants.